Evidence map›Paper›PMID 9502786›Full record

ArticleThe Journal of clinical investigation1998

Retinoic acid inhibits induction of c-Jun protein by ultraviolet radiation that occurs subsequent to activation of mitogen-activated protein kinase pathways in human skin in vivo.

G J Fisher, H S Talwar, J Lin, P Lin, F McPhillips, Z Wang, X Li, Y Wan, S Kang, J J Voorhees

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed, 1 pooled it
28.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 1 synthesis or guideline pooled it, 386 citations in OpenAlex.

  1. DNA repair enzymes in sunscreens and their impact on photoageing-A systematic review.Photodermatology, photoimmunology & photomedicine · 2020
    Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Elucidating Anti-aging and Antioxidant Activity ofCombinatorial chemistry & high throughput screening · 2025
    Article
  12. Article
  13. Article
  14. Photoprotective Effects ofInternational journal of molecular sciences · 2023
    Article
  15. Review
  16. Article
  17. Beneficial Effect ofInternational journal of molecular sciences · 2022
    Article
  18. Facial skin ageing: Key concepts and overview of processes.International journal of cosmetic science · 2022
    Review
  19. Article
  20. Article

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

G J FisherDepartment of Dermatology, University of Michigan Medical School, Ann Arbor, Michigan 48109-0609, USA. dianemch@umich.edu
H S Talwar
J Lin
P Lin
F McPhillips
Z Wang
X Li
Y Wan
S Kang
J J Voorhees
University of Michigan–Ann Arbor · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human skin is exposed daily to solar ultraviolet (UV) radiation. UV induces the matrix metalloproteinases collagenase, 92-kD gelatinase, and stromelysin, which degrade skin connective tissue and may contribute to premature skin aging (photoaging). Pretreatment of skin with all-trans retinoic acid (tRA) inhibits UV induction of matrix metalloproteinases. We investigated upstream signal transduction pathways and the mechanism of tRA inhibition of UV induction of matrix metalloproteinases in human skin in vivo. Exposure of human skin in vivo to low doses of UV activated EGF receptors, the GTP-binding regulatory protein p21Ras, and stimulated mitogen-activated protein (MAP) kinases, extracellular signal-regulated kinase (ERK), c-Jun amino-terminal kinase (JNK), and p38. Both JNK and p38 phosphorylated, and thereby activated transcription factors c-Jun and activating transcription factor 2 (ATF-2), which bound to the c-Jun promoter and upregulated c-Jun gene expression. Elevated c-Jun, in association with constitutively expressed c-Fos, formed increased levels of transcription factor activator protein (AP) 1, which is required for transcription of matrix metalloproteinases. Pretreatment of human skin with tRA inhibited UV induction of c-Jun protein and, consequently, AP-1. c-Jun protein inhibition occurred via a posttranscriptional mechanism, since tRA did not inhibit UV induction of c-Jun mRNA. These data demonstrate, for the first time, activation of MAP kinase pathways in humans in vivo, and reveal a novel posttranscriptional mechanism by which tRA antagonizes UV activation of AP-1 by inhibiting c-Jun protein induction. Inhibition of c-Jun induction likely contributes to the previously reported prevention by tRA of UV induction of AP-1-regulated matrix-degrading metalloproteinases in human skin.

Indexed as

Activating Transcription Factor 2Antineoplastic AgentsCalcium-Calmodulin-Dependent Protein KinasesCyclic AMP Response Element-Binding ProteinErbB ReceptorsGene ExpressionHumansJNK Mitogen-Activated Protein KinasesMitogen-Activated Protein KinasesNerve Tissue Proteinsp38 Mitogen-Activated Protein KinasesPromoter Regions, GeneticProto-Oncogene Proteins c-junProto-Oncogene Proteins p21(ras)Signal TransductionSkinActivating Transcription Factor 2Antineoplastic AgentsATF2 protein, humanCalcium-Calmodulin-Dependent Protein KinasesCyclic AMP Response Element-Binding ProteinErbB ReceptorsHRAS protein, humanJNK Mitogen-Activated Protein KinasesMitogen-Activated Protein KinasesNerve Tissue Proteinsp38 Mitogen-Activated Protein KinasesProto-Oncogene Proteins c-junProto-Oncogene Proteins p21(ras)Transcription Factor AP-1Transcription FactorsTretinoin

Identifiers

PMID9502786
PMCPMC508699
OpenAlexW2008301558

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.